Jules Garbus, MD
Colon & Rectal Surgery · Garden City, NYNPI 1356310809
Payments from drug & device makers
Across 14 payments — averaging $241.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Integra Lifesciences Corporation$137
- Baxter Healthcare$91
- Acell, Inc.$43
- Shire North American Group Inc$42
- Takeda Pharmaceuticals U.S.A., Inc.$39
- plus $35 from 2 others
What the payments were for
- Food & beverage$38711%
- Education$3,00089%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $3,000 |
| Integra Lifesciences Corporation | 2 | $137 |
| Baxter Healthcare | 4 | $91 |
| Acell, Inc. | 1 | $43 |
| Shire North American Group Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Alfasigma USA, Inc. | 1 | $19 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,000
How this compares
$3,387 in reported general payments places this provider in the 60th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 104 | $50,370 |
| LinzessLinaclotide | 43 | $27,445 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 81 | $1,445 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 33 | $1,102 |
| Lactulose | 44 | $1,011 |
| Hydrocortisone | 100 | $905 |
| CholestyramineCholestyramine (With Sugar) | 20 | $815 |
| Diltiazem Hcl | 13 | $815 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $761 |
| Metronidazole | 40 | $549 |
| Doxycycline Hyclate | 28 | $336 |
| Dicyclomine Hcl | 31 | $334 |
| Codeine Sulfate | 12 | $270 |
| Methylprednisolone | 20 | $150 |
| Alprazolam | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Garden City
- Cesar SanzGarden City$8K
- David RivadeneiraWoodbury$271K
- Jerald WishnerMount Kisco$246K
- Joseph TerlizziNew York$245K
- Sanghyun KimNew York$154K
- Richard WhelanNew York$120K
- Jeffrey MilsomNew York$107K
- Ziad KronfolWest Nyack$81K
- Lynn OconnorHuntington$63K
- Mehraneh JafariNew York$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.